前列腺影像报告和数据系统第2版(PI-RADS V2)联合多参数MR成像检测前列腺癌的诊断准确性:一项Meta分析
本Meta分析纳入13项研究共2049例患者,评估PI-RADS V2联合多参数MR检测前列腺癌的诊断准确性。作者结论认为PI-RADS V2似乎具有较好的诊断准确性,表现为高敏感度和中等特异度,但因异质性未能给出最佳阈值推荐。
要点
- 阳性预测值范围为0.54至0.97,阴性预测值范围为0.26至0.92,提示不同研究间预测值差异较大。
核心结论
- 现有证据表明PI-RADS V2在检测前列腺癌病灶方面似乎具有较好的诊断准确性,表现为高敏感度和中等特异度;但由于异质性,无法就最佳阈值给出推荐。
研究设计与样本
- 系统综述与Meta分析,纳入13项使用PI-RADS V2报告前列腺MRI的原始研究,共2049例患者;采用QUADAS-2工具评估方法学质量,从纳入研究获取完成2×2列联表所需数据。
诊断标准与关键数值
- 阳性预测值范围为0.54至0.97,阴性预测值范围为0.26至0.92。
临床应用与阅片要点
- 目前证据提示PI-RADS V2检测前列腺癌具有高敏感度和中等特异度,但不同研究间异质性高。
- 有经验放射科医师可提高前列腺癌检出率。
- 因异质性,原文未能就最佳诊断阈值给出推荐。
局限性
- 因异质性,无法就最佳阈值提供推荐。
- 前列腺MRI诊断领域目前存在高度异质性。
- 合并特异度仍为中等水平。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This meta-analysis was undertaken to review the diagnostic accuracy of PI-RADS V2 for prostate cancer (PCa) detection with multiparametric MR (mp-MR).
METHODS: A comprehensive literature search of electronic databases was performed by two observers independently. Inclusion criteria were original research using the PI-RADS V2 system in reporting prostate MRI. The methodological quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool. Data necessary to complete 2 × 2 contingency tables were obtained from the included studies.
RESULTS: Thirteen studies (2,049 patients) were analysed. This is an initial meta-analysis of PI-RADs V2 and the overall diagnostic accuracy in diagnosing PCa was as follows: pooled sensitivity, 0.85 (0.78-0.91); pooled specificity, 0.71 (0.60-0.80); pooled positive likelihood ratio (LR+), 2.92 (2.09-4.09); pooled negative likelihood ratio (LR-), 0.21 (0.14-0.31); pooled diagnostic odds ratio (DOR), 14.08 (7.93-25.01), respectively. Positive predictive values ranged from 0.54 to 0.97 and negative predictive values ranged from 0.26 to 0.92.
CONCLUSION: Currently available evidence indicates that PI-RADS V2 appears to have good diagnostic accuracy in patients with PCa lesions with high sensitivity and moderate specificity. However, no recommendation regarding the best threshold can be provided because of heterogeneity.
KEY POINTS: • PI-RADS V2 shows good diagnostic accuracy for PCa detection. • Initially pooled specificity of PI-RADS v2 remains moderate. • PCa detection is increased by experienced radiologists. • There is currently a high heterogeneity in prostate diagnostics with MRI.
引用
- Zhang L, Tang M, Chen S, et al. A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer. Eur Radiol. 2017. PMID: 28656462. doi:10.1007/s00330-017-4843-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。